Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Alteogen (196170) – Hana Securities | New ALT-B4 Deal Signed · Qlex Prescription Surge · SC Conversion Acceleration / 2026-08-06 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Expanding Order Opportunities · 1Q26 Earnings Beat · Global Air Defense Growth / 2026-05-08 Research
  • [IR] SK hynix (000660 / SKHY) – Q1 2024 Earnings Presentation / 2024-04-25 IR Room
  • [Research] Samsung Biologics (207940) – Yuanta Securities | US Site Acquisition · Biosecure Act Beneficiary · Plant 6 & Campus 3 Expansion / 2026-01-07 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | ESS & BBU Growth · Profit Turnaround · Core Earnings Sustainability / 2026-07-31 Research
  • [Research] Alteogen (196170) – Hana Securities | Core Business on Track · Favorable Deal Outlook · Keytruda Royalty Impact Reflected / 2026-02-19 Research
  • [IR] SK hynix (000660 / SKHY) – Q3 2025 Earnings Presentation / 2025-10-29 IR Room
  • [Research] LIG D&A (079550) – Kiwoom Securities | Order Visibility · Production Expansion · Middle East Deliveries / 2026-08-07 Research

Category: Shipbuilding

[Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Growth · Offshore Order Requirements · Global Naval Pipeline / 2026-07-13

Posted on July 13, 2026August 22, 2026 By ksb220805@gmail.com No Comments on [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Growth · Offshore Order Requirements · Global Naval Pipeline / 2026-07-13
[Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Growth · Offshore Order Requirements · Global Naval Pipeline / 2026-07-13

Brokerage : SK Securities Analyst : Seunghan Han (R.A : Seoyoung Ko) Investment Rating : BUY (Maintained) Target Price : KRW 134,000 (Lowered) Core Momentum : Sustained merchant earnings expansion driven by a rising mix of high-price vessel construction, with focus shifting to global naval pipeline diversification and essential 2H offshore plant order intake following…

Read More “[Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Growth · Offshore Order Requirements · Global Naval Pipeline / 2026-07-13” »

Research, Shipbuilding

[Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09

Posted on July 9, 2026August 22, 2026 By ksb220805@gmail.com No Comments on [Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09
[Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09

Brokerage : Daishin Securities Analyst : Jini Lee Investment Rating : BUY (Maintained) Target Price : KRW 139,000 (Lowered) Core Momentum : Near-term earnings improvement supported by the early revenue recognition of an offshore FPSO project, with long-term fundamentals anchored by diversified global naval pipelines and US auxiliary ship synergies beyond the Canadian tender outcome…

Read More “[Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09” »

Research, Shipbuilding

[Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06

Posted on July 6, 2026August 22, 2026 By ksb220805@gmail.com No Comments on [Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06
[Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06

Brokerage : Yuanta Securities Analyst : Yongmin Kim Investment Rating : BUY (Maintained) Target Price : KRW 179,000 (Maintained) Core Momentum : Merchant earnings expansion driven by an increased revenue share of high-price FY24–25 orders, with medium-to-long-term valuation upside centered on the Canadian CPSP submarine tender outcome and 2H MASGA developments 📊 1. [Valuation &…

Read More “[Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06” »

Shipbuilding, Research

[Research] Hanwha Ocean (042660) – Kiwoom | Merchant Profit Driver · High-Price Mix Scale-Up · Naval & Offshore Orders / 2026-04-29

Posted on April 29, 2026August 22, 2026 By ksb220805@gmail.com No Comments on [Research] Hanwha Ocean (042660) – Kiwoom | Merchant Profit Driver · High-Price Mix Scale-Up · Naval & Offshore Orders / 2026-04-29
[Research] Hanwha Ocean (042660) – Kiwoom | Merchant Profit Driver · High-Price Mix Scale-Up · Naval & Offshore Orders / 2026-04-29

Brokerage : Kiwoom Securities Analyst : Hangyeol Lee Investment Rating : BUY (Maintained) Target Price : KRW 179,000 (Maintained) Core Momentum : Strong corporate earnings expansion powered by the revenue recognition of high-price LNGCs secured since 2023 and structural cost cuts in commercial shipbuilding, alongside expectations for naval and offshore order intake to alleviate fixed-cost…

Read More “[Research] Hanwha Ocean (042660) – Kiwoom | Merchant Profit Driver · High-Price Mix Scale-Up · Naval & Offshore Orders / 2026-04-29” »

Shipbuilding, Research

[Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28

Posted on April 28, 2026August 22, 2026 By ksb220805@gmail.com No Comments on [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28
[Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28

Brokerage : DS Investment & Securities Analyst : Daesung Kim Investment Rating : BUY (Maintained) Target Price : KRW 170,000 (Raised) Core Momentum : Sustained commercial shipbuilding profitability driven by the declining share of low-margin legacy orders and TOP cost reductions, coupled with emerging growth catalysts from the US NGLS conceptual design contract and the…

Read More “[Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28” »

Research, Shipbuilding

[Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28

Posted on April 28, 2026August 22, 2026 By ksb220805@gmail.com No Comments on [Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28
[Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28

Brokerage : Hanwha Investment & Securities Analyst : Seongjo Bae Investment Rating : Buy (Maintained) Target Price : KRW 175,000 (Raised) Core Momentum : Substantial merchant margin surprise driven by the revenue recognition of high-price post-2024 orders and structural cost improvements across non-LNG vessel types, alongside upcoming defense milestones including KDDX order intake and Canadian…

Read More “[Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28” »

Research, Shipbuilding

Posts pagination

Previous 1 2
  • [IR] Samsung Electronics (005930) – Q4 2024 Earnings Presentation / 2025-01-31 IR Room
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research
  • [Research] Celltrion (068270) – iM Securities | New Product Mix Expansion · First-Mover Advantage · Two-Track Long-Term Strategy / 2026-07-28 Research
  • [Research] Alteogen (196170) – Shinhan Securities | Keytruda SC Growth Accelerates · Favorable Contract Terms · Early June PGR Catalysts / 2026-05-11 Research
  • [Research] Alteogen (196170) – Daishin Securities | Keytruda Qlex Commercial Milestones · RNA Modality Expansion · Platform Re-rating / 2026-08-10 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | 4Q Earnings Recovery · New Plant Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | Sequential Segment Recovery · Order Pipeline Visibility · Form Factor Diversification / 2026-04-29 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme